YolTech in Boston: 4th LNP Formulation & Process Dev Summit

Dr. Zi Jun (Emma) Wang, YolTech Co-founder, Chief Development Officer (CDO), and Chief Technology Officer (CTO), will speak at the upcoming 4th Annual LNP Formulation & Process Development Summit, taking place in Boston, USA fromApril 14–16, 2025.

As the world’s premier event dedicated to the entire lipid nanoparticle (LNP) ecosystem, the summit will bring together 50+ world-class speakers and over 300 experts in discovery, formulation, delivery, and CMC development. The goal is to accelerate next-generation LNP innovation—enhancing stability, safety, and scalability to better meet unmet clinical needs across a wide range of therapeutic areas.

Dr. Wang will deliver a keynote speech at the conference, focusing on expanding the application of lipid nanoparticles (LNPs) in development of in vivo gene-editing therapeutics.

Stay tuned as YolTech continues to lead the charge in reimagining how gene editing therapies are delivered safely and effectively using next-generation LNP platforms.